Amylyx Pharmaceuticals Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$13.47

-0.06 (-0.44%)

As of Mar 24, 2:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +175.8% upside

Low Target $28.49

Average Target $37.15

High Target $49.81

Current Price $13.47

Current
$13.47

Target
$37.15

$28.49 $37.15 avg $49.81

Scenario Analysis

Bear Case

$28.49

111.5%

Low target

Base Case

$37.15

+175.8%

Avg target

Bull Case

$49.81

+269.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$17.49

-23.0% from high

52-Week Low

$2.60

+418.1% from low

Target vs 52W High

$37.15

+112.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%